The Society of Nuclear Medicine will mark its 51st annual meeting, with more than 3,800 nuclear medicine physicians, scientists, pharmacists and technologists ready to descend on Philadelphia from June 19th through June 23rd.
SNM organizers say some of the key topics for this year's annual forum include techniques for early diagnosis of Alzheimer's disease, advanced imaging for the diagnosis, staging and treatment of cancer, nuclear cardiology, and how nuclear medicine and bioengineering have joined forces to fight cancer.
PET-CT will be at the forefront of discussions and several categorical seminars during the course of the annual meeting, along with presentations on nuclear cardiology, reimbursement, brain imaging and PET in pediatrics.
Also on the agenda are plenary sessions on Sunday, Monday and Tuesday, June 20 through June 22, respectively.
Sunday's plenary session officially launches the annual meeting with a preview of the coming week's events and the annual Henry Wagner Lectureship. The Society also will present the Georg de Hevesy and Paul C. Aebersold Awards.
On Monday, Valentin Fuster, MD, director of the Zena and Michael A. Wiener Cardiovascular Institute at Mount Sinai School of Medicine in New York, and Carlo M. Croce, MD, director of the Kimmel Cancer Center in Philadelphia, will present "New Directions in Coronary Artery Disease and Cancer."
On Tuesday, Michael J. Welch, PhD, professor in the department of radiology at Mallinckrodt Institute if Radiology speaks on "Tracer Studies From Bench to Bedside: Past, Present and Future."
SNM also plans to hold its technologist certification exam review and mock certification exam on Saturday, June 19, from 12 noon to 6 p.m.
THE EXHIBIT HALL
SNM 2004 opens its exhibit hall for three full days - Sunday, Monday & Tuesday - to approximately 150 vendors to show their products and latest technologies
GE Healthcare comes to SNM 2004 with the former Amersham plc now integrated, following GE's April acquisition of the British-based pharmaceutical company. GE plans to show the new combination of medical imaging and radiopharmaceutical resources and how the two specialties will benefit nuclear medicine and accelerate the potential for molecular medicine.
GE will upgrade the technology on its Infinia system with a 5 mm step option with Hawkeye for better resolution in SPECT/CT studies; a camera-based PET option; new detector flexibility to accommodate more patient positions; fan-beam collimation for brain studies; and productivity enhancements, including a new gantry display.
The company also is showing an advanced Discovery PET/CT application called HeartFusion, designed to non-invasively evaluate fused coronary anatomy and myocardial perfusion information for the assessment of coronary artery disease. Discovery offers 2D, 3D, 4D and dynamic imaging capabilities, CT-attenuation correction and dedicated cardiac advanced applications.
GE's PETtrace cyclotron will add a high capacity 18F-F2 target developed in
collaboration with Hammersmith Imanet, and a high specific activity 11C-methane target.
Myoview (kit for the preparation of Technetium Tc-99m Tetrofosmin for injection), developed by the former Amersham, is used to diagnose heart disease by visualizing blood flow to the heart muscle.
Philips Medical Systems is introducing JetStream Workspace, the next-generation nuclear cardiology module designed to include all imaging elements of a nuclear cardiology laboratory into one environment. JetStream makes it possible for display, processing, review, reporting and image archiving to exist at a single location or distributed throughout the department in multiple locations.
Philips also highlights its CardioMD compact, nuclear cardiology gamma camera for the office-based practice. CardioMD provides good image quality, high throughput and a small footprint, according to the company. This highly innovative imaging system offers complete cardiac imaging capabilities and provides an ideal combination of easy-to-use features that both enhance departmental workflow and allow for simple patient setup.
Philips soon will offer its attenuation correction (AC) technology - VantagePro - on the CardioMD. FDA 510(k) clearance for Vantage Pro on the gamma camera is pending.
Currently, CardioMD features cardiac image processing applications, including AutoSPECT Plus, AutoQUANT Plus, CardiaQ and Emory Tool Box, a quantification and review application for Cardiac SPECT.